Alterations in the pattern and efficiency of alternative splicing of several pre-mRNAs (e.g. CD44, BRCA1, WT-1) have been implicated in tumourigenesis and correlated with tumour progression [16, 17]. This evidence concerns the gene BRCA1 and neoplasm.